메뉴 건너뛰기




Volumn 101, Issue 4, 2016, Pages 407-416

New and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemia

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; DASATINIB; IMATINIB; RUXOLITINIB; TRANSCRIPTION FACTOR 7 LIKE 1; TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTOME; ANTINEOPLASTIC AGENT; ONCOPROTEIN; PYRAZOLE DERIVATIVE; TUMOR MARKER;

EID: 84962632701     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2015.141101     Document Type: Review
Times cited : (160)

References (98)
  • 1
    • 84903541143 scopus 로고    scopus 로고
    • Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): A randomised controlled trial
    • Vora A, Goulden N, Mitchell C, et al. Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial. Lancet Oncol. 2014; 15(8): 809-818.
    • (2014) Lancet Oncol , vol.15 , Issue.8 , pp. 809-818
    • Vora, A.1    Goulden, N.2    Mitchell, C.3
  • 2
    • 84875273960 scopus 로고    scopus 로고
    • Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): A randomised controlled trial
    • Vora A, Goulden N, Wade R, et al. Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial. Lancet Oncol. 2013; 14(3): 199-209.
    • (2013) Lancet Oncol , vol.14 , Issue.3 , pp. 199-209
    • Vora, A.1    Goulden, N.2    Wade, R.3
  • 3
    • 41349100708 scopus 로고    scopus 로고
    • In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: Final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)
    • Goldstone AH, Richards SM, Lazarus HM, et al. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood. 2008; 111(4): 1827-1833.
    • (2008) Blood , vol.111 , Issue.4 , pp. 1827-1833
    • Goldstone, A.H.1    Richards, S.M.2    Lazarus, H.M.3
  • 4
    • 75649092322 scopus 로고    scopus 로고
    • A populationbased cytogenetic study of adults with acute lymphoblastic leukemia
    • Moorman AV, Chilton L, Wilkinson J, Ensor HM, Bown N, Proctor SJ. A populationbased cytogenetic study of adults with acute lymphoblastic leukemia. Blood. 2010; 115(2): 206-214.
    • (2010) Blood , vol.115 , Issue.2 , pp. 206-214
    • Moorman, A.V.1    Chilton, L.2    Wilkinson, J.3    Ensor, H.M.4    Bown, N.5    Proctor, S.J.6
  • 5
    • 84860012521 scopus 로고    scopus 로고
    • Outcomes in older adults with acute lymphoblastic leukaemia (ALL): Results from the international MRC UKALL XII/ECOG2993 trial
    • Sive JI, Buck G, Fielding A, et al. Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial. Br J Haematol. 2012; 157(4): 463-471.
    • (2012) Br J Haematol , vol.157 , Issue.4 , pp. 463-471
    • Sive, J.I.1    Buck, G.2    Fielding, A.3
  • 6
    • 77951441599 scopus 로고    scopus 로고
    • Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: Results in 3184 patients of the AIEOP-BFM ALL 2000 study
    • Conter V, Bartram CR, Valsecchi MG, et al. Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study. Blood. 2010; 115(16): 3206-3214.
    • (2010) Blood , vol.115 , Issue.16 , pp. 3206-3214
    • Conter, V.1    Bartram, C.R.2    Valsecchi, M.G.3
  • 7
    • 84907080295 scopus 로고    scopus 로고
    • Targetable kinase-activating lesions in Phlike acute lymphoblastic leukemia
    • Roberts KG, Li Y, Payne-Turner D, et al. Targetable kinase-activating lesions in Phlike acute lymphoblastic leukemia. N Engl J Med. 2014; 371(11): 1005-1015.
    • (2014) N Engl J Med , vol.371 , Issue.11 , pp. 1005-1015
    • Roberts, K.G.1    Li, Y.2    Payne-Turner, D.3
  • 8
    • 84859209595 scopus 로고    scopus 로고
    • The clinical relevance of chromosomal and genomic abnormalities in Bcell precursor acute lymphoblastic leukaemia
    • Moorman AV. The clinical relevance of chromosomal and genomic abnormalities in Bcell precursor acute lymphoblastic leukaemia. Blood Rev. 2012; 26(3): 123-135.
    • (2012) Blood Rev , vol.26 , Issue.3 , pp. 123-135
    • Moorman, A.V.1
  • 9
    • 84878341989 scopus 로고    scopus 로고
    • Acute lymphoblastic leukaemia
    • Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukaemia. Lancet. 2013; 381 (9881): 1943-1955.
    • (2013) Lancet , vol.381 , Issue.9881 , pp. 1943-1955
    • Inaba, H.1    Greaves, M.2    Mullighan, C.G.3
  • 10
    • 33644545382 scopus 로고    scopus 로고
    • Infection, immune responses and the aetiology of childhood leukaemia
    • Greaves M. Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer. 2006; 6(3): 193-203.
    • (2006) Nat Rev Cancer , vol.6 , Issue.3 , pp. 193-203
    • Greaves, M.1
  • 11
    • 78751644099 scopus 로고    scopus 로고
    • Genetic variegation of clonal architecture and propagating cells in leukaemia
    • Anderson K, Lutz C, van Delft FW, et al. Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature. 2011; 469(7330): 356-361.
    • (2011) Nature , vol.469 , Issue.7330 , pp. 356-361
    • Anderson, K.1    Lutz, C.2    van Delft, F.W.3
  • 12
    • 84879593764 scopus 로고    scopus 로고
    • Genes commonly deleted in childhood Bcell precursor acute lymphoblastic leukemia: Association with cytogenetics and clinical features
    • Schwab CJ, Chilton L, Morrison H, et al. Genes commonly deleted in childhood Bcell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features. Haematologica. 2013; 98(7): 1081-1088.
    • (2013) Haematologica , vol.98 , Issue.7 , pp. 1081-1088
    • Schwab, C.J.1    Chilton, L.2    Morrison, H.3
  • 13
    • 0141923915 scopus 로고    scopus 로고
    • Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia
    • Moorman AV, Richards SM, Martineau M, et al. Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia. Blood. 2003; 102(8): 2756-2762.
    • (2003) Blood , vol.102 , Issue.8 , pp. 2756-2762
    • Moorman, A.V.1    Richards, S.M.2    Martineau, M.3
  • 14
    • 34249065493 scopus 로고    scopus 로고
    • Specific extra chromosomes occur in a modal number dependent pattern in pediatric acute lymphoblastic leukemia
    • Heerema NA, Raimondi SC, Anderson JR, et al. Specific extra chromosomes occur in a modal number dependent pattern in pediatric acute lymphoblastic leukemia. Genes Chromosomes and Cancer. 2007; 46(7): 684-693.
    • (2007) Genes Chromosomes and Cancer , vol.46 , Issue.7 , pp. 684-693
    • Heerema, N.A.1    Raimondi, S.C.2    Anderson, J.R.3
  • 15
    • 20844436312 scopus 로고    scopus 로고
    • High concordance from independent studies by the Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10, and 17 in children with NCI Standard-Risk B-precursor Acute Lymphoblastic Leukemia: A Children's Oncology Group (COG) initiative
    • Sutcliffe MJ, Shuster JJ, Sather HN, et al. High concordance from independent studies by the Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10, and 17 in children with NCI Standard-Risk B-precursor Acute Lymphoblastic Leukemia: a Children's Oncology Group (COG) initiative. Leukemia. 2005; 19(5): 734-740.
    • (2005) Leukemia , vol.19 , Issue.5 , pp. 734-740
    • Sutcliffe, M.J.1    Shuster, J.J.2    Sather, H.N.3
  • 16
    • 84878392379 scopus 로고    scopus 로고
    • Hyperdiploidy with 58-66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results
    • Dastugue N, Suciu S, Plat G, et al. Hyperdiploidy with 58-66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results. Blood. 2013; 121(13): 2415-2423.
    • (2013) Blood , vol.121 , Issue.13 , pp. 2415-2423
    • Dastugue, N.1    Suciu, S.2    Plat, G.3
  • 17
    • 84883634157 scopus 로고    scopus 로고
    • High modal number and triple trisomies are highly correlated favorable factors in childhood B-cell precursor high hyperdiploid acute lymphoblastic leukemia treated according to the NOPHO ALL 1992/2000 protocols
    • Paulsson K, Forestier E, Andersen MK, et al. High modal number and triple trisomies are highly correlated favorable factors in childhood B-cell precursor high hyperdiploid acute lymphoblastic leukemia treated according to the NOPHO ALL 1992/2000 protocols. Haematologica. 2013; 98(9): 1424-1432.
    • (2013) Haematologica , vol.98 , Issue.9 , pp. 1424-1432
    • Paulsson, K.1    Forestier, E.2    Andersen, M.K.3
  • 18
    • 85014252003 scopus 로고    scopus 로고
    • ETV6/AML1 fusion by FISH in adult acute lymphoblastic leukemia
    • Jabbar Al Obaidi MS, Martineau M, Bennett CF, et al. ETV6/AML1 fusion by FISH in adult acute lymphoblastic leukemia. Leukemia. 2002; 16(4): 669-674.
    • (2002) Leukemia , vol.16 , Issue.4 , pp. 669-674
    • Jabbar Al Obaidi, M.S.1    Martineau, M.2    Bennett, C.F.3
  • 19
    • 77952305440 scopus 로고    scopus 로고
    • Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: Results from the UK Medical Research Council ALL97/99 randomised trial
    • Moorman AV, Ensor HM, Richards SM, et al. Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial. Lancet Oncol. 2010; 11(5): 429-438.
    • (2010) Lancet Oncol , vol.11 , Issue.5 , pp. 429-438
    • Moorman, A.V.1    Ensor, H.M.2    Richards, S.M.3
  • 20
    • 84904054301 scopus 로고    scopus 로고
    • High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): Cytogenetic features, clinical characteristics and outcome
    • Chilton L, Buck G, Harrison CJ, et al. High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): cytogenetic features, clinical characteristics and outcome. Leukemia. 2014; 28(7): 1511-1518.
    • (2014) Leukemia , vol.28 , Issue.7 , pp. 1511-1518
    • Chilton, L.1    Buck, G.2    Harrison, C.J.3
  • 21
    • 84887318371 scopus 로고    scopus 로고
    • Longterm follow-up of ETV6-RUNX1 ALL reveals that NCI risk, rather than secondary genetic abnormalities, is the key risk factor
    • Enshaei A, Schwab CJ, Konn ZJ, et al. Longterm follow-up of ETV6-RUNX1 ALL reveals that NCI risk, rather than secondary genetic abnormalities, is the key risk factor. Leukemia. 2013; 27(11): 2256-2259.
    • (2013) Leukemia , vol.27 , Issue.11 , pp. 2256-2259
    • Enshaei, A.1    Schwab, C.J.2    Konn, Z.J.3
  • 22
    • 84856756817 scopus 로고    scopus 로고
    • ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: Improved outcome with contemporary therapy
    • Bhojwani D, Pei D, Sandlund JT, et al. ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy. Leukemia. 2012; 26(2): 265-270.
    • (2012) Leukemia , vol.26 , Issue.2 , pp. 265-270
    • Bhojwani, D.1    Pei, D.2    Sandlund, J.T.3
  • 23
    • 84862321772 scopus 로고    scopus 로고
    • Additional aberrations of the ETV6 and RUNX1 genes have no prognostic impact in 229 t(12; 21)(p13; q22)-positive B-cell precursor acute lymphoblastic leukaemias treated according to the NOPHO-ALL-2000 protocol
    • Barbany G, Andersen MK, Autio K, et al. Additional aberrations of the ETV6 and RUNX1 genes have no prognostic impact in 229 t(12; 21)(p13; q22)-positive B-cell precursor acute lymphoblastic leukaemias treated according to the NOPHO-ALL-2000 protocol. Leuk Res. 2012; 36(7): 936-938.
    • (2012) Leuk Res , vol.36 , Issue.7 , pp. 936-938
    • Barbany, G.1    Andersen, M.K.2    Autio, K.3
  • 24
    • 67650421868 scopus 로고    scopus 로고
    • High hyperdiploid childhood acute lymphoblastic leukemia
    • Paulsson K, Johansson B. High hyperdiploid childhood acute lymphoblastic leukemia. Genes Chromosomes Cancer. 2009; 48(8): 637-660.
    • (2009) Genes Chromosomes Cancer , vol.48 , Issue.8 , pp. 637-660
    • Paulsson, K.1    Johansson, B.2
  • 25
    • 84962691029 scopus 로고    scopus 로고
    • Prognostic Value of Rare IKZF1 deletions in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia: An International Collaborative Study
    • Boer JM, Veer Avd, Rizopoulos D, et al. Prognostic Value of Rare IKZF1 deletions in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia: An International Collaborative Study. Blood. 2014; 124(21): 368.
    • (2014) Blood , vol.124 , Issue.21 , pp. 368
    • Boer, J.M.1    Veer Avd, R.D.2
  • 26
    • 84887320453 scopus 로고    scopus 로고
    • The MLL recombinome of acute leukemias in 2013
    • Meyer C, Hofmann J, Burmeister T, et al. The MLL recombinome of acute leukemias in 2013. Leukemia. 2013; 27(11): 2165-2176.
    • (2013) Leukemia , vol.27 , Issue.11 , pp. 2165-2176
    • Meyer, C.1    Hofmann, J.2    Burmeister, T.3
  • 27
    • 2942563738 scopus 로고    scopus 로고
    • Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia
    • Harrison CJ, Moorman AV, Broadfield ZJ, et al. Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia. Br J Haematol. 2004; 125(5): 552-559.
    • (2004) Br J Haematol , vol.125 , Issue.5 , pp. 552-559
    • Harrison, C.J.1    Moorman, A.V.2    Broadfield, Z.J.3
  • 28
    • 84874647204 scopus 로고    scopus 로고
    • The genomic landscape of hypodiploid acute lymphoblastic leukemia
    • Holmfeldt L, Wei L, Diaz-Flores E, et al. The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat Genet. 2013; 45 (3): 242-252.
    • (2013) Nat Genet , vol.45 , Issue.3 , pp. 242-252
    • Holmfeldt, L.1    Wei, L.2    Diaz-Flores, E.3
  • 29
    • 34447519040 scopus 로고    scopus 로고
    • A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): An observational study and a multicentre randomised trial
    • Pieters R, Schrappe M, De LP, et al. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet. 2007; 370(9583): 240-250.
    • (2007) Lancet , vol.370 , Issue.9583 , pp. 240-250
    • Pieters, R.1    Schrappe, M.2    De, L.P.3
  • 30
    • 58149398623 scopus 로고    scopus 로고
    • Translation of the Philadelphia chromosome into therapy for CML
    • Druker BJ. Translation of the Philadelphia chromosome into therapy for CML. Blood. 2008; 112(13): 4808-4817.
    • (2008) Blood , vol.112 , Issue.13 , pp. 4808-4817
    • Druker, B.J.1
  • 31
    • 84894066916 scopus 로고    scopus 로고
    • UKALLXII/ECOG2993: Addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia
    • Fielding AK, Rowe JM, Buck G, et al. UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia. Blood. 2014; 123(6): 843-850.
    • (2014) Blood , vol.123 , Issue.6 , pp. 843-850
    • Fielding, A.K.1    Rowe, J.M.2    Buck, G.3
  • 32
    • 84865539834 scopus 로고    scopus 로고
    • Imatinib after induction for treatment of children and adolescents with Philadelphiachromosome-positive acute lymphoblastic leukaemia (EsPhALL): A randomised, openlabel, intergroup study
    • Biondi A, Schrappe M, De Lorenzo P, et al. Imatinib after induction for treatment of children and adolescents with Philadelphiachromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, openlabel, intergroup study. Lancet Oncol. 2012; 13(9): 936-945.
    • (2012) Lancet Oncol , vol.13 , Issue.9 , pp. 936-945
    • Biondi, A.1    Schrappe, M.2    De Lorenzo, P.3
  • 33
    • 79960044951 scopus 로고    scopus 로고
    • MLLrearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L
    • Bernt KM, Zhu N, Sinha AU, et al. MLLrearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L. Cancer Cell. 2011; 20(1): 66-78.
    • (2011) Cancer Cell , vol.20 , Issue.1 , pp. 66-78
    • Bernt, K.M.1    Zhu, N.2    Sinha, A.U.3
  • 35
    • 34147135183 scopus 로고    scopus 로고
    • Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): Analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 Trial
    • Moorman AV, Harrison CJ, Buck GA, et al. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): Analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 Trial. Blood. 2007; 109(8): 3189-3197.
    • (2007) Blood , vol.109 , Issue.8 , pp. 3189-3197
    • Moorman, A.V.1    Harrison, C.J.2    Buck, G.A.3
  • 36
    • 84919348129 scopus 로고    scopus 로고
    • Prognostic significance of complex karyotype and monosomal karyotype in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols
    • Motllo C, Ribera JM, Morgades M, et al. Prognostic significance of complex karyotype and monosomal karyotype in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols. Cancer. 2014; 120(24): 3958-3964.
    • (2014) Cancer , vol.120 , Issue.24 , pp. 3958-3964
    • Motllo, C.1    Ribera, J.M.2    Morgades, M.3
  • 37
    • 41949083910 scopus 로고    scopus 로고
    • Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: Results of Southwest Oncology Group 9400 study
    • Pullarkat V, Slovak ML, Kopecky KJ, Forman SJ, Appelbaum FR. Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of Southwest Oncology Group 9400 study. Blood. 2008; 111(5): 2563-2572.
    • (2008) Blood , vol.111 , Issue.5 , pp. 2563-2572
    • Pullarkat, V.1    Slovak, M.L.2    Kopecky, K.J.3    Forman, S.J.4    Appelbaum, F.R.5
  • 38
    • 33947382184 scopus 로고    scopus 로고
    • Molecular Cytogenetic Characterisation of TCF3 (E2A)/19p13. 3 Rearrangements in BCell Precursor Acute Lymphoblastic Leukaemia
    • Barber KE, Harrison CJ, Broadfield ZJ, et al. Molecular Cytogenetic Characterisation of TCF3 (E2A)/19p13. 3 Rearrangements in BCell Precursor Acute Lymphoblastic Leukaemia. Genes Chromosomes Cancer. 2007; 46(5): 478-486.
    • (2007) Genes Chromosomes Cancer , vol.46 , Issue.5 , pp. 478-486
    • Barber, K.E.1    Harrison, C.J.2    Broadfield, Z.J.3
  • 39
    • 0025063464 scopus 로고
    • Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications on the t(1; 19)
    • Raimondi S, Behm F, Robertson PK, et al. Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications on the t(1; 19). J Clin Oncol. 1990; 8: 1380-1388.
    • (1990) J Clin Oncol , vol.8 , pp. 1380-1388
    • Raimondi, S.1    Behm, F.2    Robertson, P.K.3
  • 40
    • 68749108126 scopus 로고    scopus 로고
    • Increased risk for CNS relapse in pre-B cell leukemia with the t(1; 19)/TCF3-PBX1
    • Jeha S, Pei D, Raimondi SC, et al. Increased risk for CNS relapse in pre-B cell leukemia with the t(1; 19)/TCF3-PBX1. Leukemia. 2009; 23(8): 1406-1409.
    • (2009) Leukemia , vol.23 , Issue.8 , pp. 1406-1409
    • Jeha, S.1    Pei, D.2    Raimondi, S.C.3
  • 41
    • 36348988513 scopus 로고    scopus 로고
    • Incidence and outcome of TCF3-PBX1-positive acute lymphoblastic leukemia in Austrian children
    • Kager L, Lion T, Attarbaschi A, et al. Incidence and outcome of TCF3-PBX1-positive acute lymphoblastic leukemia in Austrian children. Haematologica. 2007; 92(11): 1561-1564.
    • (2007) Haematologica , vol.92 , Issue.11 , pp. 1561-1564
    • Kager, L.1    Lion, T.2    Attarbaschi, A.3
  • 42
    • 0029867127 scopus 로고    scopus 로고
    • Cytogenetic Abnormalities in Adult Acute Lymphoblastic Leukemia: Correlations with Hematologic Findings and Outcome. A Collaborative Study of the Groupe Francais de Cytogenetique Hematologique
    • GFCH. Cytogenetic Abnormalities in Adult Acute Lymphoblastic Leukemia: Correlations with Hematologic Findings and Outcome. A Collaborative Study of the Groupe Francais de Cytogenetique Hematologique. Blood. 1996; 87(8): 3135-3142.
    • (1996) Blood , vol.87 , Issue.8 , pp. 3135-3142
    • GFCH1
  • 43
    • 65649106232 scopus 로고    scopus 로고
    • Adults with acute lymphoblastic leukemia and translocation (1; 19) abnormality have a favorable outcome with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with methotrexate and high-dose cytarabine chemotherapy
    • Garg R, Kantarjian H, Thomas D, et al. Adults with acute lymphoblastic leukemia and translocation (1; 19) abnormality have a favorable outcome with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with methotrexate and high-dose cytarabine chemotherapy. Cancer. 2009; 115(10): 2147-2154.
    • (2009) Cancer , vol.115 , Issue.10 , pp. 2147-2154
    • Garg, R.1    Kantarjian, H.2    Thomas, D.3
  • 44
    • 84902685650 scopus 로고    scopus 로고
    • Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia
    • Beldjord K, Chevret S, Asnafi V, et al. Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia. Blood. 2014; 123(24): 3739-3749.
    • (2014) Blood , vol.123 , Issue.24 , pp. 3739-3749
    • Beldjord, K.1    Chevret, S.2    Asnafi, V.3
  • 45
    • 84897528140 scopus 로고    scopus 로고
    • Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia
    • Li Y, Schwab C, Ryan SL, et al. Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia. Nature. 2014; 508(7494): 98-102.
    • (2014) Nature , vol.508 , Issue.7494 , pp. 98-102
    • Li, Y.1    Schwab, C.2    Ryan, S.L.3
  • 46
    • 77957361896 scopus 로고    scopus 로고
    • Detection of prognostically relevant genetic abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: Recommendations from the Biology and Diagnosis Committee of the International Berlin-Frankfurt-Munster study group
    • Harrison CJ, Haas O, Harbott J, et al. Detection of prognostically relevant genetic abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: recommendations from the Biology and Diagnosis Committee of the International Berlin-Frankfurt-Munster study group. Br J Haematol. 2010; 151(2): 132-142.
    • (2010) Br J Haematol , vol.151 , Issue.2 , pp. 132-142
    • Harrison, C.J.1    Haas, O.2    Harbott, J.3
  • 47
    • 33947257508 scopus 로고    scopus 로고
    • Prognosis of children with acute lymphoblastic leukaemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21)
    • Moorman AV, Richards SM, Robinson HM, et al. Prognosis of children with acute lymphoblastic leukaemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21). Blood. 2007; 109: 2327-2330.
    • (2007) Blood , vol.109 , pp. 2327-2330
    • Moorman, A.V.1    Richards, S.M.2    Robinson, H.M.3
  • 48
    • 84899979360 scopus 로고    scopus 로고
    • An international study of intrachromosomal amplification of chromosome 21 (iAMP21): Cytogenetic characterization and outcome
    • Harrison CJ, Moorman AV, Schwab C, et al. An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome. Leukemia. 2014; 28(5): 1015-1021.
    • (2014) Leukemia , vol.28 , Issue.5 , pp. 1015-1021
    • Harrison, C.J.1    Moorman, A.V.2    Schwab, C.3
  • 49
    • 84887513571 scopus 로고    scopus 로고
    • Risk-directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukemia and intrachromosomal amplification of chromosome 21: A comparison of the MRC ALL97/99 and UKALL2003 trials
    • Moorman AV, Robinson H, Schwab C, et al. Risk-directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukemia and intrachromosomal amplification of chromosome 21: a comparison of the MRC ALL97/99 and UKALL2003 trials. J Clin Oncol. 2013; 31(27): 3389-3396.
    • (2013) J Clin Oncol , vol.31 , Issue.27 , pp. 3389-3396
    • Moorman, A.V.1    Robinson, H.2    Schwab, C.3
  • 50
    • 84897568967 scopus 로고    scopus 로고
    • Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standardrisk children's oncology group studies: A report from the children's oncology group
    • Heerema NA, Carroll AJ, Devidas M, et al. Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standardrisk children's oncology group studies: a report from the children's oncology group. J Clin Oncol. 2013; 31(27): 3397-3402.
    • (2013) J Clin Oncol , vol.31 , Issue.27 , pp. 3397-3402
    • Heerema, N.A.1    Carroll, A.J.2    Devidas, M.3
  • 51
    • 84923900276 scopus 로고    scopus 로고
    • Minimal residual disease-based treatment is adequate for relapse-prone childhood acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21: The experience of the ALLBFM 2000 trial
    • Attarbaschi A, Panzer-Grumayer R, Mann G, et al. Minimal residual disease-based treatment is adequate for relapse-prone childhood acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21: the experience of the ALLBFM 2000 trial. Klin Padiatr. 2014; 226(6-7): 338-343.
    • (2014) Klin Padiatr , vol.226 , Issue.6-7 , pp. 338-343
    • Attarbaschi, A.1    Panzer-Grumayer, R.2    Mann, G.3
  • 52
    • 84865571594 scopus 로고    scopus 로고
    • Treatment outcome of CRLF2-rearranged childhood acute lymphoblastic leukaemia: A comparative analysis of the AIEOP-BFM and UK NCRI-CCLG study groups
    • Attarbaschi A, Morak M, Cario G, et al. Treatment outcome of CRLF2-rearranged childhood acute lymphoblastic leukaemia: a comparative analysis of the AIEOP-BFM and UK NCRI-CCLG study groups. Br J Haematol. 2012; 158(6): 772-777.
    • (2012) Br J Haematol , vol.158 , Issue.6 , pp. 772-777
    • Attarbaschi, A.1    Morak, M.2    Cario, G.3
  • 53
    • 77949910163 scopus 로고    scopus 로고
    • Immunoglobulin heavy chain locus chromosomal translocations in B-cell precursor acute lymphoblastic leukemia: Rare clinical curios or potent genetic drivers?
    • Dyer MJ, Akasaka T, Capasso M, et al. Immunoglobulin heavy chain locus chromosomal translocations in B-cell precursor acute lymphoblastic leukemia: rare clinical curios or potent genetic drivers? Blood. 2010; 115(8): 1490-1499.
    • (2010) Blood , vol.115 , Issue.8 , pp. 1490-1499
    • Dyer, M.J.1    Akasaka, T.2    Capasso, M.3
  • 54
    • 84902980183 scopus 로고    scopus 로고
    • IGH@ translocations are prevalent in teenagers and young adults with acute lymphoblastic leukemia and are associated with a poor outcome
    • Russell LJ, Enshaei A, Jones L, et al. IGH@ translocations are prevalent in teenagers and young adults with acute lymphoblastic leukemia and are associated with a poor outcome. J Clin Oncol. 2014; 32(14): 1453-1462.
    • (2014) J Clin Oncol , vol.32 , Issue.14 , pp. 1453-1462
    • Russell, L.J.1    Enshaei, A.2    Jones, L.3
  • 55
    • 38349177862 scopus 로고    scopus 로고
    • Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray
    • Kawamata N, Ogawa S, Zimmermann M, et al. Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray. Blood. 2008; 111(2): 776-784.
    • (2008) Blood , vol.111 , Issue.2 , pp. 776-784
    • Kawamata, N.1    Ogawa, S.2    Zimmermann, M.3
  • 56
    • 44349174780 scopus 로고    scopus 로고
    • Microdeletions are a general feature of adult and adolescent acute lymphoblastic leukemia: Unexpected similarities with pediatric disease
    • Paulsson K, Cazier JB, Macdougall F, et al. Microdeletions are a general feature of adult and adolescent acute lymphoblastic leukemia: Unexpected similarities with pediatric disease. Proc Natl Acad Sci USA. 2008; 105(18): 6708-6713.
    • (2008) Proc Natl Acad Sci USA , vol.105 , Issue.18 , pp. 6708-6713
    • Paulsson, K.1    Cazier, J.B.2    Macdougall, F.3
  • 57
    • 34249668665 scopus 로고    scopus 로고
    • Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridization
    • Strefford JC, Worley H, Barber K, et al. Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridization. Oncogene. 2007; 26(29): 4306-4318.
    • (2007) Oncogene , vol.26 , Issue.29 , pp. 4306-4318
    • Strefford, J.C.1    Worley, H.2    Barber, K.3
  • 58
    • 34147224008 scopus 로고    scopus 로고
    • Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia
    • Mullighan CG, Goorha S, Radtke I, et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature. 2007; 446(7137): 758-764.
    • (2007) Nature , vol.446 , Issue.7137 , pp. 758-764
    • Mullighan, C.G.1    Goorha, S.2    Radtke, I.3
  • 59
    • 57149118627 scopus 로고    scopus 로고
    • Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia
    • Mullighan CG, Phillips LA, Su X, et al. Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science. 2008; 322(5906): 1377-1380.
    • (2008) Science , vol.322 , Issue.5906 , pp. 1377-1380
    • Mullighan, C.G.1    Phillips, L.A.2    Su, X.3
  • 60
    • 81155123233 scopus 로고    scopus 로고
    • Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies
    • Hogan LE, Meyer JA, Yang J, et al. Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies. Blood. 2011; 118(19): 5218-5226.
    • (2011) Blood , vol.118 , Issue.19 , pp. 5218-5226
    • Hogan, L.E.1    Meyer, J.A.2    Yang, J.3
  • 61
    • 61549114444 scopus 로고    scopus 로고
    • Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia
    • Yang JJ, Bhojwani D, Yang W, et al. Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia. Blood. 2008; 112(10): 4178-4183.
    • (2008) Blood , vol.112 , Issue.10 , pp. 4178-4183
    • Yang, J.J.1    Bhojwani, D.2    Yang, W.3
  • 62
    • 19044399684 scopus 로고    scopus 로고
    • Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling
    • Yeoh EJ, Ross ME, Shurtleff SA, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell. 2002; 1(2): 133-143.
    • (2002) Cancer Cell , vol.1 , Issue.2 , pp. 133-143
    • Yeoh, E.J.1    Ross, M.E.2    Shurtleff, S.A.3
  • 63
    • 78649742010 scopus 로고    scopus 로고
    • Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: Correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome
    • Harvey RC, Mullighan CG, Wang X, et al. Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. Blood. 2010; 116 (23): 4874-4884.
    • (2010) Blood , vol.116 , Issue.23 , pp. 4874-4884
    • Harvey, R.C.1    Mullighan, C.G.2    Wang, X.3
  • 64
    • 43049139905 scopus 로고    scopus 로고
    • BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros
    • Mullighan CG, Miller CB, Radtke I, et al. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature. 2008; 453(7191): 110-114.
    • (2008) Nature , vol.453 , Issue.7191 , pp. 110-114
    • Mullighan, C.G.1    Miller, C.B.2    Radtke, I.3
  • 65
    • 70449719091 scopus 로고    scopus 로고
    • IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: A GIMEMA AL WP report
    • Martinelli G, Iacobucci I, Storlazzi CT, et al. IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report. J Clin Oncol. 2009; 27(31): 5202-5207.
    • (2009) J Clin Oncol , vol.27 , Issue.31 , pp. 5202-5207
    • Martinelli, G.1    Iacobucci, I.2    Storlazzi, C.T.3
  • 66
    • 84897566266 scopus 로고    scopus 로고
    • IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL
    • van der Veer A, Zaliova M, Mottadelli F, et al. IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL. Blood. 2014; 123(11): 1691-1698.
    • (2014) Blood , vol.123 , Issue.11 , pp. 1691-1698
    • van der Veer, A.1    Zaliova, M.2    Mottadelli, F.3
  • 67
    • 84867403265 scopus 로고    scopus 로고
    • Outcome in children with Down's syndrome and acute lymphoblastic leukemia: Role of IKZF1 deletions and CRLF2 aberrations
    • Buitenkamp TD, Pieters R, Gallimore NE, et al. Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations. Leukemia. 2012; 26(10): 2204-2211.
    • (2012) Leukemia , vol.26 , Issue.10 , pp. 2204-2211
    • Buitenkamp, T.D.1    Pieters, R.2    Gallimore, N.E.3
  • 68
    • 58749109707 scopus 로고    scopus 로고
    • Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia
    • Mullighan CG, Su X, Zhang J, et al. Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia. N Engl J Med. 2009; 360(5): 470-480.
    • (2009) N Engl J Med , vol.360 , Issue.5 , pp. 470-480
    • Mullighan, C.G.1    Su, X.2    Zhang, J.3
  • 69
    • 84881021736 scopus 로고    scopus 로고
    • What is the relevance of Ikaros gene deletions as prognostic marker in pediatric Philadelphia negative B-cell precursor acute lymphoblastic leukemia?
    • Palmi C, Valsecchi MG, Longinotti G, et al. What is the relevance of Ikaros gene deletions as prognostic marker in pediatric Philadelphia negative B-cell precursor acute lymphoblastic leukemia? Haematologica. 2013; 98(8): 1226-1231.
    • (2013) Haematologica , vol.98 , Issue.8 , pp. 1226-1231
    • Palmi, C.1    Valsecchi, M.G.2    Longinotti, G.3
  • 70
    • 79751538993 scopus 로고    scopus 로고
    • Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia
    • Waanders E, van der Velden VH, van der Schoot CE, et al. Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia. Leukemia. 2011; 25(2): 254-258.
    • (2011) Leukemia , vol.25 , Issue.2 , pp. 254-258
    • Waanders, E.1    van der Velden, V.H.2    van der Schoot, C.E.3
  • 71
    • 84865745212 scopus 로고    scopus 로고
    • IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia
    • Moorman AV, Schwab C, Ensor HM, et al. IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia. J Clin Oncol. 2012; 30(25): 3100-3108.
    • (2012) J Clin Oncol , vol.30 , Issue.25 , pp. 3100-3108
    • Moorman, A.V.1    Schwab, C.2    Ensor, H.M.3
  • 72
    • 84891850778 scopus 로고    scopus 로고
    • An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions
    • Clappier E, Auclerc MF, Rapion J, et al. An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions. Leukemia. 2014; 28(1): 70-77.
    • (2014) Leukemia , vol.28 , Issue.1 , pp. 70-77
    • Clappier, E.1    Auclerc, M.F.2    Rapion, J.3
  • 73
    • 84891877413 scopus 로고    scopus 로고
    • ERG deletion is associated with CD2 and attenuates the negative impact of IKZF1 deletion in childhood acute lymphoblastic leukemia
    • Zaliova M, Zimmermannova O, Dorge P, et al. ERG deletion is associated with CD2 and attenuates the negative impact of IKZF1 deletion in childhood acute lymphoblastic leukemia. Leukemia. 2014; 28(1): 182-185.
    • (2014) Leukemia , vol.28 , Issue.1 , pp. 182-185
    • Zaliova, M.1    Zimmermannova, O.2    Dorge, P.3
  • 74
    • 84859820034 scopus 로고    scopus 로고
    • Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: A Children's Oncology Group study
    • Chen IM, Harvey RC, Mullighan CG, et al. Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study. Blood. 2012; 119(15): 3512-3522.
    • (2012) Blood , vol.119 , Issue.15 , pp. 3512-3522
    • Chen, I.M.1    Harvey, R.C.2    Mullighan, C.G.3
  • 75
    • 84888253484 scopus 로고    scopus 로고
    • Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with Bcell precursor ALL
    • van der Veer A, Waanders E, Pieters R, et al. Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with Bcell precursor ALL. Blood. 2013; 122(15): 2622-2629.
    • (2013) Blood , vol.122 , Issue.15 , pp. 2622-2629
    • van der Veer, A.1    Waanders, E.2    Pieters, R.3
  • 77
    • 84962669041 scopus 로고    scopus 로고
    • The Clinical Relevance Of Genetics In Predicting Outcome After a First Relapse In Children With B-Cell Precursor Acute Lymphoblastic Leukaemia
    • Moorman AV, Erhorn A, Parker C, et al. The Clinical Relevance Of Genetics In Predicting Outcome After a First Relapse In Children With B-Cell Precursor Acute Lymphoblastic Leukaemia. Blood. 2013; 122(21): 2566.
    • (2013) Blood , vol.122 , Issue.21 , pp. 2566
    • Moorman, A.V.1    Erhorn, A.2    Parker, C.3
  • 78
    • 70350519430 scopus 로고    scopus 로고
    • Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia
    • Russell LJ, Capasso M, Vater I, et al. Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia. Blood. 2009; 114(13): 2688-2698.
    • (2009) Blood , vol.114 , Issue.13 , pp. 2688-2698
    • Russell, L.J.1    Capasso, M.2    Vater, I.3
  • 79
    • 70350680415 scopus 로고    scopus 로고
    • Rearrangement of CRLF2 in B-progenitor-and Down syndrome-associated acute lymphoblastic leukemia
    • Mullighan CG, Collins-Underwood JR, Phillips LA, et al. Rearrangement of CRLF2 in B-progenitor-and Down syndrome-associated acute lymphoblastic leukemia. Nat Genet. 2009; 41(11): 1243-1246.
    • (2009) Nat Genet , vol.41 , Issue.11 , pp. 1243-1246
    • Mullighan, C.G.1    Collins-Underwood, J.R.2    Phillips, L.A.3
  • 80
    • 77949425065 scopus 로고    scopus 로고
    • Activating mutation in the TSLPR gene in Bcell precursor lymphoblastic leukemia
    • Chapiro E, Russell L, Lainey E, et al. Activating mutation in the TSLPR gene in Bcell precursor lymphoblastic leukemia. Leukemia. 2010; 24(3): 642-645.
    • (2010) Leukemia , vol.24 , Issue.3 , pp. 642-645
    • Chapiro, E.1    Russell, L.2    Lainey, E.3
  • 81
    • 84864440264 scopus 로고    scopus 로고
    • Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia
    • Tasian SK, Doral MY, Borowitz MJ, et al. Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia. Blood. 2012; 120(4): 833-842.
    • (2012) Blood , vol.120 , Issue.4 , pp. 833-842
    • Tasian, S.K.1    Doral, M.Y.2    Borowitz, M.J.3
  • 82
    • 77954500629 scopus 로고    scopus 로고
    • Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol
    • Cario G, Zimmermann M, Romey R, et al. Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol. Blood. 2010; 115(26): 5393-5397.
    • (2010) Blood , vol.115 , Issue.26 , pp. 5393-5397
    • Cario, G.1    Zimmermann, M.2    Romey, R.3
  • 83
    • 77954516863 scopus 로고    scopus 로고
    • Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia
    • Harvey RC, Mullighan CG, Chen IM, et al. Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia. Blood. 2010; 115(26): 5312-5321.
    • (2010) Blood , vol.115 , Issue.26 , pp. 5312-5321
    • Harvey, R.C.1    Mullighan, C.G.2    Chen, I.M.3
  • 84
    • 79951845044 scopus 로고    scopus 로고
    • Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: Results from the MRC ALL97 clinical trial
    • Ensor HM, Schwab C, Russell LJ, et al. Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trial. Blood. 2011; 117(7): 2129-2136.
    • (2011) Blood , vol.117 , Issue.7 , pp. 2129-2136
    • Ensor, H.M.1    Schwab, C.2    Russell, L.J.3
  • 85
    • 84867404417 scopus 로고    scopus 로고
    • Poor Prognosis for P2RY8-CRLF2 Fusion but not for CRLF2 Over-expression in Children with Intermediate Risk B-Cell Precursor Acute Lymphoblastic Leukemia
    • Palmi C, Vendramini E, Silvestri D, et al. Poor Prognosis for P2RY8-CRLF2 Fusion but not for CRLF2 Over-expression in Children with Intermediate Risk B-Cell Precursor Acute Lymphoblastic Leukemia. Leukemia. 2012; 26(10): 2245-2253.
    • (2012) Leukemia , vol.26 , Issue.10 , pp. 2245-2253
    • Palmi, C.1    Vendramini, E.2    Silvestri, D.3
  • 86
    • 84871481072 scopus 로고    scopus 로고
    • Small sizes and indolent evolutionary dynamics challenge the potential role of P2RY8-CRLF2-harboring clones as main relapse-driving force in childhood ALL
    • Morak M, Attarbaschi A, Fischer S, et al. Small sizes and indolent evolutionary dynamics challenge the potential role of P2RY8-CRLF2-harboring clones as main relapse-driving force in childhood ALL. Blood. 2012; 120(26): 5134-42.
    • (2012) Blood , vol.120 , Issue.26 , pp. 5134-5142
    • Morak, M.1    Attarbaschi, A.2    Fischer, S.3
  • 87
    • 84865118132 scopus 로고    scopus 로고
    • Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia
    • Roberts KG, Morin RD, Zhang J, et al. Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. Cancer Cell. 2012; 22(2): 153-166.
    • (2012) Cancer Cell , vol.22 , Issue.2 , pp. 153-166
    • Roberts, K.G.1    Morin, R.D.2    Zhang, J.3
  • 88
    • 84907360666 scopus 로고    scopus 로고
    • A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia
    • Moorman AV, Enshaei A, Schwab C, et al. A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia. Blood. 2014; 124(9): 1434-1444.
    • (2014) Blood , vol.124 , Issue.9 , pp. 1434-1444
    • Moorman, A.V.1    Enshaei, A.2    Schwab, C.3
  • 89
    • 58749097408 scopus 로고    scopus 로고
    • A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: A genome-wide classification study
    • Den Boer ML, van Slegtenhorst M, De Menezes RX, et al. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. Lancet Oncol. 2009; 10(2): 125-134.
    • (2009) Lancet Oncol , vol.10 , Issue.2 , pp. 125-134
    • Den Boer, M.L.1    van Slegtenhorst, M.2    De Menezes, R.X.3
  • 90
    • 85008372514 scopus 로고    scopus 로고
    • An Analysis Of Ph-Like ALL In Japanese Patients
    • Kiyokawa N, Iijima K, Yoshihara H, et al. An Analysis Of Ph-Like ALL In Japanese Patients. Blood. 2013; 122(21): 352.
    • (2013) Blood , vol.122 , Issue.21 , pp. 352
    • Kiyokawa, N.1    Iijima, K.2    Yoshihara, H.3
  • 91
    • 85008333473 scopus 로고    scopus 로고
    • Philadelphia-Like Signature In Childhood Acute Lymphoblastic Leukemia: The AIEOP Experience
    • Kronnie Gt, Silvestri D, Vendramini E, et al. Philadelphia-Like Signature In Childhood Acute Lymphoblastic Leukemia: The AIEOP Experience. Blood. 2013; 122(21): 353.
    • (2013) Blood , vol.122 , Issue.21 , pp. 353
    • Kronnie, G.1    Silvestri, D.2    Vendramini, E.3
  • 92
    • 84962651909 scopus 로고    scopus 로고
    • BCR-ABL1-Like Cases In Pediatric Acute Lymphoblastic Leukemia: A Comparison Between COG/St. Jude and Dutch DCOG Signatures
    • Boer JM, Marchante JRM, Horstmann MA, et al. BCR-ABL1-Like Cases In Pediatric Acute Lymphoblastic Leukemia: A Comparison Between COG/St. Jude and Dutch DCOG Signatures. Blood. 2013; 122(21): 2633.
    • (2013) Blood , vol.122 , Issue.21 , pp. 2633
    • Boer, J.M.1    Marchante, J.R.M.2    Horstmann, M.A.3
  • 93
    • 84901693202 scopus 로고    scopus 로고
    • ATF7IP as a novel PDGFRB fusion partner in acute lymphoblastic leukaemia in children
    • Kobayashi K, Mitsui K, Ichikawa H, et al. ATF7IP as a novel PDGFRB fusion partner in acute lymphoblastic leukaemia in children. Br J Haematol. 2014; 165(6): 836-841.
    • (2014) Br J Haematol , vol.165 , Issue.6 , pp. 836-841
    • Kobayashi, K.1    Mitsui, K.2    Ichikawa, H.3
  • 94
    • 84898466517 scopus 로고    scopus 로고
    • RNA-seq identifies clinically relevant fusion genes in leukemia including a novel MEF2D/CSF1R fusion responsive to imatinib
    • Lilljebjorn H, Agerstam H, Orsmark-Pietras C, et al. RNA-seq identifies clinically relevant fusion genes in leukemia including a novel MEF2D/CSF1R fusion responsive to imatinib. Leukemia. 2014; 28(4): 977-979.
    • (2014) Leukemia , vol.28 , Issue.4 , pp. 977-979
    • Lilljebjorn, H.1    Agerstam, H.2    Orsmark-Pietras, C.3
  • 95
    • 84886996732 scopus 로고    scopus 로고
    • Successful tyrosine kinase inhibitor therapy in a refractory B-cell precursor acute lymphoblastic leukemia with EBF1-PDGFRB fusion
    • Lengline E, Beldjord K, Dombret H, Soulier J, Boissel N, Clappier E. Successful tyrosine kinase inhibitor therapy in a refractory B-cell precursor acute lymphoblastic leukemia with EBF1-PDGFRB fusion. Haematologica. 2013; 98(11): e146-148.
    • (2013) Haematologica , vol.98 , Issue.11 , pp. e146-e148
    • Lengline, E.1    Beldjord, K.2    Dombret, H.3    Soulier, J.4    Boissel, N.5    Clappier, E.6
  • 96
    • 84886513092 scopus 로고    scopus 로고
    • Tyrosine kinase inhibitor therapy induces remission in a patient with refractory EBF1-PDGFRB-positive acute lymphoblastic leukemia
    • Weston BW, Hayden MA, Roberts KG, et al. Tyrosine kinase inhibitor therapy induces remission in a patient with refractory EBF1-PDGFRB-positive acute lymphoblastic leukemia. J Clin Oncol. 2013; 31(25): e413-416.
    • (2013) J Clin Oncol , vol.31 , Issue.25 , pp. e413-e416
    • Weston, B.W.1    Hayden, M.A.2    Roberts, K.G.3
  • 97
    • 85020160452 scopus 로고    scopus 로고
    • EBF1-PDGFRB-Fusion in Paediatric Acute Lymphoblastic Leukaemia (ALL): Genetic Profile and Clinical Implications
    • Schwab C, Andrews R, Chilton L, et al. EBF1-PDGFRB-Fusion in Paediatric Acute Lymphoblastic Leukaemia (ALL): Genetic Profile and Clinical Implications. Blood. 2014; 124(21): 1068.
    • (2014) Blood , vol.124 , Issue.21 , pp. 1068
    • Schwab, C.1    Andrews, R.2    Chilton, L.3
  • 98
    • 84962671585 scopus 로고    scopus 로고
    • SSBP2-CSF1R Is a Recurrent Fusion in BOther Acute Lymphoblastic Leukaemia with Variable Clinical Outcome
    • Schwab C, Andrews R, Chilton L, et al. SSBP2-CSF1R Is a Recurrent Fusion in BOther Acute Lymphoblastic Leukaemia with Variable Clinical Outcome. Blood. 2014; 124(21): 3773.
    • (2014) Blood , vol.124 , Issue.21 , pp. 3773
    • Schwab, C.1    Andrews, R.2    Chilton, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.